ERAWATCH Country Report 2012: Israel by GARCIA Abraham
  
 
  
 
 
 
 
  
2 0 1 4  
 
 
Abraham García, 
based on the 2011 Country Report by Y. Fisher  
and M. Eilan 
 
ERAWATCH Country Reports 2012: Israel 
Report EUR 26299 EN  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
European Commission 
Joint Research Centre 
Institute for Prospective Technological Studies  
 
Contact information 
Address: Edificio Expo. c/ Inca Garcilaso, 3. E-41092 Seville (Spain) 
E-mail: jrc-ipts-secretariat@ec.europa.eu 
Tel.: +34 954488318 
Fax: +34 954488300 
 
http://ipts.jrc.ec.europa.eu 
http://www.jrc.ec.europa.eu 
 
 
Legal Notice 
Neither the European Commission nor any person acting on behalf of the Commission 
is responsible for the use which might be made of this publication. 
 
Europe Direct is a service to help you find answers to your questions about the European Union 
Freephone number (*): 00 800 6 7 8 9 10 11 
(*) Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed. 
 
A great deal of additional information on the European Union is available on the Internet. 
It can be accessed through the Europa server http://europa.eu/. 
 
JRC85289 
 
EUR 26299 EN 
 
ISBN 978-92-79-34535-7 (pdf) 
 
ISSN 1831-9424 (online)  
 
doi:10.2791/4621 
 
Luxembourg: Publications Office of the European Union, 2014 
 
© European Union, 2014 
 
Reproduction is authorised provided the source is acknowledged. 
 
Printed in Spain 
 1 
 
 
ACKNOWLEDGEMENTS AND FURTHER INFORMATION  
This analytical country report is one of a series of annual ERAWATCH reports produced for EU 
Member States and Countries Associated to the Seventh Framework Programme for Research of 
the European Union (FP7). ERAWATCH is a joint initiative of the European Commission's 
Directorate General for Research and Innovation and Joint Research Centre.  
The Country Report 2012 builds on and updates the 2011 edition. The report identifies the 
structural challenges of the national research and innovation system and assesses the match 
between the national priorities and the structural challenges, highlighting the latest developments, 
their dynamics and impact in the overall national context.  
Prepared by Abraham Garcia, this report is a comprehensive revision and update of the 
ERAWATCH Country Report 2011 for Israel by Yacov Fisher and Michael Eilan. The first draft 
of this report was produced in December 2012 and was focused on developments taking place in 
the previous twelve months. The report has also benefited from comments and suggestions of 
Mark Boden from JRC-IPTS who reviewed the draft report. The contributions and comments 
from Mr. Marcel Shaton of Israel Europe R&D Directorate are also gratefully acknowledged.   
The report is currently only published in electronic format and is available on the ERAWATCH 
website. Comments on this report are welcome and should be addressed to jrc-ipts-erawatch-
helpdesk@ec.europa.eu. 
Copyright of this document belongs to the European Commission. Neither the European Commission, nor any 
person acting on its behalf, may be held responsible for the use of the information contained in this document, or for 
any errors which, despite careful preparation and checking, may appear. The report does not represent the official 
opinion of the European Commission, nor that of the national authorities. It has been prepared by independent 
external experts, who provide evidence based analysis of the national Research and Innovation system and policy.  
  
 2 
 
 
EXECUTIVE SUMMARY 
 
So far the economic crisis has had less effect on Israel, which has continued growing at a 
moderate rate. During 2012, GDP grew by 3.3 %, slightly below that in the last two quarters of 
2011 when growth was already lower than its long-term average. The moderation of growth in 
business activity during the current period was to a large extent the result of the crisis in the 
Eurozone and the slowdown in global growth. 
 
However GERD, measured as a percentage of GDP, has been constantly declining, from 4.49% 
in 2009, to 4.38% in 2011 despite a market increase in government expenditure (GEBOARD), 
highlighting the very high exposure of the research and innovations system to global financial 
conditions, which stems from the very high share of business in funding R&D, 80 % of the total 
GERD.  
 
There have been no recent major changes in the governance of the government funded RDI. At 
the end of 2011, four research areas were designated as national priority fields: brain science, 
supercomputing and cyber security, oceanography and alternative transportation fuels. The two 
main RDI bodies are – the Council of Higher Education (CHE) through its Planning and 
Budgetary Committee (VATAT) and the Office of the Chief Scientist (OCS) in the Ministry of 
Industry, Trade and Employment (MOITAL). Also important are the strong collaborations with 
the Ministry of Finance as can be seen in the programmes launched in collaboration with the rest 
of RDI bodies.  
 
The OCS published the structure of the RDI incentives in Israel. The different domestic 
programmes are classified according to the development of the innovation: Pre-seed and seed 
programmes focusing on innovation at a very early stage, and offering the protection of the 
technological incubators; pre-competitive and long term programmes for encourage collaboration 
among industrial companies, and between the companies and researchers from academic 
institutions; and the competitive R&D gives grants to “approved R&D programmes”, which are 
programmes lasting one or more years, resulting in the development of innovations. 
 
The academic year 2011-12 is the second year in which VATAT’s six years plan to revive Israeli 
higher education and university based research has been implemented. The plan calls for a 30% 
increase in budgets over the course of the plan, and nearly doubling the funding for competitive 
grants. 
 
The decision of the cabinet to increase the Science and Technology Ministry’s budget for its 
regional research and development centres can be understood as an instrument for Smart 
Specialization. The budget was increased by €1.8 million, effectively a tripling of the budget for 
the eight centres located in the periphery ranging from Kiryat Shmona and the Golan Heights in 
the north to Negev desert in the south. The Ministry is a partner in the establishment of these 
centres, in guiding its scientific activity and substantially participates in their funding. They were 
established in the periphery to draw young, leading scientists into these areas. 
 
The Israeli RDI system faces three major structural challenges that require systematic solutions. 
These are as follows: 
1. Reviving research in Israeli universities: Budgets for Israeli universities essentially stagnated 
during the first decade of the century despite a growth in the student body, causing a decline 
in available funding for research, deterioration of teaching and research infrastructures and an 
accelerating brain drain.  
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2. Over-reliance on ICT: Companies dealing with computing and communications 
technologies are one of the mainstays of the Israeli economy. However the period of 
explosive growth for ICT is over globally and policymakers have been trying for a number of 
years through several instruments to find new engines of growth. 
3. The precarious state of Venture Capital: Returns on VC investments in Israel by and large 
match returns in the US, where results have been disappointing compared to other financial 
investments during the past decade. The total funds available for investments are at a low 
level, and Israeli fund management companies urgently need to raise new funds to continue 
their important role in funding Israeli start-ups. 
Israeli RDI governance does not have a tradition of formally articulating priorities as part of an 
open policy making process. Nevertheless, the new Vatat six-year plan does lay out a clear vision, 
by implication, of a set of priorities chiefly calling both for a higher degree of excellence and a 
higher degree of specialisation in university research. 
 
The priorities of the OCS, though rarely articulated as such, are evident from the changing nature 
of measures issued over the years. A major shift during the past few years has been the inclusion 
of priorities with a societal/economic slant beyond the traditional OCS approach of encouraging 
technological excellence wherever it happens. These priorities range from measures to improve 
innovation in traditional industries to measures to encourage technology firms to set up 
operations in peripheral parts of the country. 
 
In terms of venture capital the priorities are very clear. If the Israeli fund management companies 
do not manage to raise new funds during the next two years a highly important part of the 
innovation funding mechanism in Israel will be in jeopardy. The Finance Ministry decision to 
insure a quarter of the risk of Israeli institutional investors, who join funds as limited partners, is 
a direct reaction to this priority. 
 
Looking at the match between the challenges, priorities and means used to address the needs of 
the RDI system, Vatat's six year plan, coupled with the I-CORE project, seems to be a 
comprehensive approach that looks towards creating foci of research excellence while reviving 
the entire academic research sector.  
 
The need to diversify beyond ICT is a far more complex challenge because it involves creating an 
infrastructure not only of research but also of human skills and the financial means to realize 
commercial potentials. The creation of the government backed biotech VC fund is a step in the 
right direction as are a number of OCS measures intended to stimulate non-ICT innovation 
issued during the past few years. But the challenge is deeper because of the breadth of the 
scientific and technological infrastructure needed to create new areas of high added value for 
Israel's knowledge intensive industries. 
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1 INTRODUCTION  
 
Israel is a small country with a population of population of 7.9 million as of January 2013. GDP 
per capita reached €23, 355 in 2011, and GDP growth reached 3.3% in 2012. During this year, 
business activity in Israel continued to grow at the moderate rate to which the economy had 
converged during the second half of 2011. During 2012, GDP grew by 3.3 percent, slightly below 
that in the last two quarters of 2011 when growth was already lower than its long-term average. 
Growth in business sector output during the first quarter slowed markedly relative to the second 
half of 2011 and stood at 2.8 percent. The moderation of growth in business activity during the 
current period was, to a large extent, the result of the crisis in the Eurozone and the slowdown in 
global growth. (Bank of Israel) 
 
Research and innovation are central pillars of the economy. GERD reached 4.4% of GDP in 
2011 compared to the EU average of 2.09% in 2011, with the business sector playing a major 
part in funding R&D. BERD accounted for 80.2% of GERD compared to the EU average of 
62.4% in 2011 and for 3.51% of GDP compared to the EU average of 1.26%. The government's 
role in funding university-based research is commensurately smaller with R&D performed by 
HEIs reaching 12.6% compared to the EU average of 24% 
 
As for human resources for S&T, the total number of recipients of second degrees in science and 
engineering grew by 7.3% compared to the EU average of 4% between 2000 and 2008. However, 
in the near future the situation might be less promising owing to the lower levels of educational 
attainment among Arabs and ultra-orthodox Jews who make up 20 and 10% of the population 
respectively. Vatat programmes to make higher education more accessible to these population 
groups was discussed in the ERAWATCH 2010 report1, but it is still too early to judge the 
effectiveness of these programmes. 
 
A major input problem is in research infrastructures, which were largely neglected between 2000 
and 2010 with the exception of the area of nanotechnology, which was addressed by the Israel 
Nanotechnology Initiative, funded partly by the government and partly by donors. The Vatat six-
year plan is supposed to address this issue, partly through the I-CORE centres, by it has not yet 
published the full plan, which is said to be roughly equivalent to the European RI roadmap. 
 
Output as measured by scientific publications declined from 1.1% of the global total in 2000 to 
0.9% in 2009. In terms of EPO patent applications per GDP Israel is the best performing 
country, as it is in PCT patent applications for health technologies. In high-tech EPO patent 
applications it is third after Finland and Sweden. In terms of ERC grants, Israel is ranked sixth in 
terms of the absolute number of grantees after Germany, the UK, France, Italy and the 
Netherlands. There are three Israeli universities in the ranking of the top 20 winners of ERC 
grants.  
 
Latest figures, as October 2011, from the European Commission CORDA database, show that 
1,102 Israeli researchers were participating in 900 signed agreements under FP7 and benefiting 
from €420 million: 40% from ERC grants; followed by 20% in ICT and 10% from Marie Curie 
Actions. Israel's top five European collaborators were Germany, UK, Italy, France and Spain. 
Just over 70% of the funding went to institutes of higher education. The most active 
organizations in terms of funding received were the Weizmann Institute, the Hebrew University 
and the Technion. 
                                                 
1
 ERAWATCH Network (2010): Israel Country Report. 
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The main players in Israel's national research and innovation system, responsible for policy-
making and governance, remain the Office of the Chief Scientist (OCS) in the Ministry of 
Industry, Trade and Employment, responsible for industrial R&D, and the Planning & Budgeting 
Committee (known as the Vatat) of the Council for Higher Education, which covers academic 
R&D. However, since 2011, the Ministry of Finance, the ultimate source of funds for R&D 
initiated by the government and academe (GBAORD and HERD respectively), has become 
much more involved in innovation policy making. The heightened involvement of the Finance 
Ministry has helped increase the cooperation and coordination between all entities involved in 
innovation policy, including the OCS and Vatat.  
 
A lesser player both in budget and influence is the Ministry of Science and Technology which 
funds some small thematic research centres, runs 10 small regional research centres and is 
responsible for some aspects of international scientific cooperation. Under the Ministry's aegis is 
the National Council for Research and Development, a body that has statutory authority to 
devise policy and advise the government, but has been largely ineffective in recent years. 
 
Outside of government, most academic research is carried out in seven research universities. 
PROs do not play a central role except in the field of agriculture. R&D in the business sector is 
divided between indigenous firms, many of which went public on NASDAQ, subsidiaries of 
multinational, mainly American corporations, and a large number of technological start-up 
companies. Many of the local subsidiaries of multinationals were set up after the acquisition of 
local start-ups. One of the problems of Israel's relatively large venture capital industry, (see 
section 2), is that is has become far more difficult to float Israeli companies on NASDAQ, the 
preferred option in terms of liquidity and visibility, meaning that most of the prevalent strategy 
for Israeli start-ups is through M&A.  
 
In terms of specialisation, there are two main fields of expertise, one which has been translated 
into noted commercial success and another which has only partially delivered on expectations. 
There is a broad range of distinct successful ICT clusters in Israel with expertise ranging from 
semiconductors though communications to data security and various kinds of software. 
Academically, life sciences are another strong suit but this has been translated into notable 
success only in the field of medical devices. Persistent government efforts to stimulate 
commercial success in pharmaceutical biotechnology have won only partial success (excluding 
Teva Pharmaceutical Industries – a humongous international firm based in Israel). Another major 
area  of expertise in knowledge intensive industries is defence exports, about which most 
information is classified. Press reports estimated the total volume of defence exports in 2010 at 
more than €5.7b. About 80% of the output of Israel's defence industries goes to exports, since 
the Israeli army cannot on its own finance the immense costs involved in developing modern 
weapons systems.  
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2 RECENT DEVELOPMENTS OF THE 
RESEARCH AND INNOVATION POLICY 
AND SYSTEM  
 
2.1 National economic and political context 
 
As mentioned above, the national economic context of Israel is characterised by a slowdown in 
the pace of growth, 3.3 percent during 2012. (The previous years was growing at an average 
higher than 4%). According to the Bank of Israel, this is due largely as a side effect of the 
situation in Europe and in the rest of the world. Activity in manufacturing slowed as a result of 
the decline in the export of goods at all levels of technology intensity. Nonetheless, the level of 
exports has remained high in historical terms. (Bank of Israel) 
 
Israel is a small and relatively knowledge-intensive country, with a strong business sector. Israel's 
main strength is the research intensity of its private sector, as indicated by a very high business 
expenditure on R&D and strong patenting activity. In 2012, business activity in Israel continued 
to grow at the moderate rate, to which the economy had converged during the second half of 
2011. During 2012, GDP grew by 3.3 percent, slightly below that in the second semester of 2011 
when growth was already lower than its long-term average. Growth in business sector output 
during the first quarter slowed markedly relative to the two previous quarters and stood at 2.8 
percent. The slowdown in the growth of business activity during 2012 was, to a large extent, the 
result of the crisis in the eurozone and the slowdown in global growth. In addition, activity in 
manufacturing slowed, as a result of the decline in the export of goods at all levels of technology 
intensity. Nonetheless, the level of exports remained high in historical terms. (Bank of Israel) 
 
In April 2012 a major change occurred in the Minister of Science and Technology when 
Professor Ehud Gazit was named chief scientist of the Ministry by Daniel Herschkowitz. Prof. 
Ehud Gazit is a world-renowned researcher in the field of nanotechnology. He will replace the 
outgoing chief scientist, Professor Danny Weiss. The chief scientist had hoped to receive an 
additional 60 € million, as he claimed in interviews with the media to have run out of budget. 
This is not the first time the chief scientist's budget for grants has run out in the middle of the 
year - in fact it has been happening regularly in recent years. Demand for grants has grown as the 
global economic crisis and slowdown has worsened and other funding sources have dried up. 
 
The two main highlights related to the innovation policy discussed in the media in 2012 are: brain 
drain, the incapacity of Israel to attract and maintain top researchers; and the risk of being a start 
up nation with need to build larger companies for the long run and creation of jobs.  
 
Concerning brain drain, the State of Israel made a strategic decision to promote the return of 
researchers who are Israeli citizens based outside of Israel to academia and industry in Israel. In 
March 2010 the Israeli Government decided to establish a series of Academic Excellence Centres 
that would create appropriate professional opportunities for scientific researchers. At the same 
meeting, the Government decided on another measure, with efforts to be made to promote the 
return of Israeli academics in general to Israel, and in particular of researchers to the business 
sector, thus helping industry deepen its competitive edge: applied innovation. The programme is 
inter–ministerial, with partners – the OCS, Ministry of Immigration absorption, the Council for 
Higher Education/Vatat and the Ministry of Finance. It is led by the OCS and will include: 
creation of an information centres, employment opportunity leads and work placement 
assistance, financial assistance to selected R&D projects, meeting the established OCS 
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requirements. MATIMOP, serving as the international arm of the OCS at the Ministry of 
Industry, Trade and Labour, is in charge of the programme's execution.  
 
2.2 Funding trends 
 
 
2009 (a) 2010 (a) 2011 (a) 
EU average 
2011 (b) 
GDP growth rate 0,84 4,85 4,75 - 0.3 (2012) 
GERD (% of GDP) 4,49 4,34 4,38 2.03s (2011) 
GERD (euro per capita) 824,12 872,56 880,34 510.5s (2011) 
GBAORD - Total R&D 
appropriations (€ million) 
857,88 961,71 1003,32 91,277.1 
(EU27 total 
2011) 
R&D  funded by Business Enterprise 
Sector (% of GDP)  
3,58 3,44 3,51 1.26 (2011) 
R&D performed by HEIs  (% of 
GERD) 
13,08 13,26 12,60 24% (2011) 
R&D performed by Government 
Sector (% of GERD) 
3,82 3,90 3,74 12.7% (2011) 
R&D performed by Business 
Enterprise Sector (% of GERD) 
79,58 79,21 80,25 62.4% (2011) 
GDP growth rate 0,84 4,85 4,75 - 0.3 (2012) 
GERD (% of GDP) 4,49 4,34 4,38 2.03s (2011) 
Sources: (a) OECD, (b) EUROSTAT 
 
The global economic crisis has had a definite impact on R&D funding in Israel as can be seen in 
the table above. GERD, measured as a percentage of GDP, has been in constant decline, falling 
from 4.49% in 2009 to 4.38% in 2011, despite a marked increase in government expenditure 
(GBOARD). This highlights the very high exposure of the research and innovation system to 
global financial conditions, which stems from the very high share of business in funding R&D.  
The total GERD figures relate only to civilian R&D, as there are no unclassified data on the total 
expenditure of the large defence related R&D system. The government has never set out specific 
targets for R&D expenditure, and is unlikely to do so in the future. 
 
The contribution of the business sector to the funding of R&D, keeps on rising, with its share of 
GERD reaching 80.2% in 2012, with a total expenditure of €6156.47 million. These levels, 
although normal for Israel, are surprisingly high, especially when compared with the EU 2011 
average, where BERD contributes to 64.4% of the GERD.  
 
In 2011, the ratio of BERD to GDP in Israel is twice the EU average, with 3.51%  although this 
is a lower proportion than in 2009. However, it seems to have recovered from the situation of 
2010 (3.44%). In general, however, funding from the private sector has been relatively unaffected 
by the global crisis. 
 
The evolution of the public sector contribution is weaker. The proportion of contribution to 
GERD by the High Education Institutions (HEI) has shown a slow down due to budget cuts. 
The assignment of funding by the public sector does not seem to be keeping pace with economic 
growth. 
 
In reaction to the global crisis that started in 2008 funding for innovation through the OCS 
increased in 2010 by 20% compared to 2007, but from 2001 to 2011, the budget has declined  
35% in real terms. A large part of the OCS budget is predicated on co-financing by the private 
sector, ranging from 50-70% co-financing by the private sector in R&D Fund grants to 15% co-
financing in the incubator programme. 
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Most of the thematic civilian research in Israel is carried out under the funding of the Seventh 
Framework Programme (FP7), which is of central importance to the Israeli R&D system. In 
2010, before the beginning of the Vatat six-year plan, FP7 funding of university based research 
was actually higher than funding for competitive funds from the ISF. This proportion is likely to 
change over the next six years as the ISF budget grows, but the Framework Programmes will 
remain of central importance to the national research system.   
 
 
2.3 New policy measures 
 
At the Chief Scientist's Annual Conference for Research and Development held on 3 May 2012, 
the Ministry of Industry, Trade and Labour's Chief Scientist announced the launching of new 
OCS programmes. These include:  
  
A new early stage technology programme created as a response to a decline in early stage 
investment.  The OCS already devotes a large part of its budget to supporting seed ventures, but 
the sector has had an unusually hard time raising funds because of the global economic 
environment. The new programme will be designed to leverage private capital invested in seed 
companies. The OCS plans the creation of a dedicated post for supervising it. 
 
Kamin, part of the pre-competitive and long term programmes, is intended to promote applied 
research and provide an additional bridge between basic and applied research for those not yet 
ready for commercial investment.  It is intended to encourage academics to pursue research in 
areas of potential commercial interest. Although managed by the OCS’ Magnet Organization it is 
launched in coordination with the Council of Higher Education and the Finance Ministry. 
 
Tzatam is a grants programme for the purchase of R&D equipment intended for experienced 
companies specializing in providing research services in the field of life sciences. €7.2 million has 
been allocated for the project, over a three year period. An additional €7.2 million has been 
allocated specifically for stem-cell research equipment.  Tzatam is a TELEM instrument. TELEM 
is a voluntary partnership between the four organizations that support R&D in Israel: Ministry of 
Industry Trade and Labour, the OCS of the Ministry of Science and Technology, the VATAT 
and the Ministry of Finance. 
 
Meimad is a collaborative programme to promote new ideas and new technologies that can serve 
both commercial applications and military needs. It is launched between the Ministry of Defence, 
the OCS and the Ministry of Finance. 
 
 
2.4 Recent policy documents  
 
One of the most important policy documents is the list of R&D incentives in Israel published by 
the Ministry of Industry, Trade and Labour. The document structures the Domestic R&D 
incentives in the following blocks: 
 
Competitive R&D: The R&D Fund is the main instrument of The R&D Law. It gives grants to 
“Approved R&D Programmes”, which are programmes lasting one or more years, resulting in 
the development of a new product or process. A research committee, headed by the Chief 
Scientist, is the organ assigned with awarding the grants, according to a set of terms and 
conditions. Grants are from 20 percent to 50 percent of the total approved R&D expenditures of 
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the approved projects. The annual budget is approximately  €300 million spent in the support of 
the R&D run by hundreds of companies. A special track is dedicated to traditional industries that 
move towards innovation, and to large companies that are based in the periphery of the industrial 
Israeli centres and commit to hiring employees living in that area. 
 
Pre seed and Seed Programmes. The primary goal is to transform innovative technological ideas, 
that are too risky and at too early a stage for private investment, into viable start-up companies 
that, after the incubator term, are capable of raising money from the private sector and can 
operate on their own. For a period of up to two years (Biotech and Cleantech projects up to 
three years), the programme provides entrepreneurs, whose projects were approved by the 
Incubators Committee, with R&D and marketing grants, infrastructure, technological and 
business guidance, legal and regulatory advice, and administrative assistance. 
 
Pre -competitive and long term R&D programmes, also know under the name of MAGNET (the 
acronym in Hebrew for Generic Pre-Competitive R&D), encourage collaboration among 
industrial companies, and between the companies and researchers from academic institutions, 
through several instruments that deal with innovative technologies. These instruments seek to 
develop Israel's industrial infrastructure by supporting the R&D activities and sharing 
technological knowledge among the participants. MAGNET works under the formation of 
consortia made up of industrial companies and academic institutions, in order to jointly develop 
generic, pre-competitive technologies. The duration of a MAGNET consortium is 3-5 years. 
Grants are up to 66% of the approved budget for industry and up to 80% for the academic 
institution. 
 
Special Programmes: Institutional investments in Israeli High Tech, government supports is 
reflected by a partial protection of up to 25% of their losses, should such occur, of the 
institution’s investment in Knowledge Intensive activities in Israel, allocated with €50million. 
Brain drain programmes (see 2.1 above) and the development of solutions for people with special 
needs, defined as “physical, psychological, mental or cognitive disability – permanent or 
temporary -- resulting in a fundamental disruption of essential daily functions”. 
 
 
2.5 Research and innovation system changes 
 
 
Israel has never had formalized research or innovation policies in the sense of producing policy 
documents that lay out long term strategies for the entire system with strategic goals and 
numerate targets. Until fairly recently, research and innovation were not even considered by the 
same department in the Finance Ministry, and coordination between the two policy fields was on 
an ad hoc basis. 
 
The level of coordination has improved to a certain degree during the past four years but 
functionally the research and innovation policies should be still considered separately. Research 
policy is made and enacted by the Council of Higher Education through its Planning and 
Budgetary Committee, commonly known by its Hebrew acronym, Vatat, while innovation policy 
is made and managed by the OCS in the Industry Ministry.  
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2.6 Regional and/or National Research and Innovation 
Strategies on Smart Specialisation (RIS3) 
 
 
The decision of the cabinet to increase the Science and Technology Ministry’s budget for its 
regional research and development centres can be interpreted as a measure for Smart 
Specialization. The budget was increased by €1.8 million, a tripling of the budget for the eight 
centres located in peripheral areas, ranging from Kiryat Shmona and the Golan Heights in the 
north to the Negev desert in the south. The Ministry is a partner in the establishment of these 
centres, in guiding its scientific activity and contributing substantially in their funding. 
 
The Regional Research and Development Centers have been established in the peripheral areas 
to draw young, leading scientists into these areas. The centres were established to contribute to 
the improvement of local society and to raise the level of local education. Furthermore, the 
centres' research focuses on local challenges, conditions and resources to provide solutions for 
local needs. The Regional Research and Development Centers present a model that is unique to 
the State of Israel and is of a ground-breaking nature. 
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3 STRUCTURAL CHALLENGES FACING THE 
NATIONAL SYSTEM 
 
The Israeli research and innovation system faces three deep structural challenges that derive both 
from internal factors and from shifts in the global marketplace. These are long term challenges 
that predate the global economic crisis that started in 2008, even though the crisis may have 
highlighted their urgency. They require the kind of long term responses that have helped the 
Israeli research and innovation system excel in the previous two decades. 
 
At least two of these challenges stem partly from this same success. The ability to attract private 
investment in R&D is what enabled Israel to achieve its top rank in the Innovation Union 
scoreboard of R&D intensity2. However, this same success led to underinvestment in other areas. 
Like most structural challenges, these challenges are extensively interrelated and touch on many 
other issues of concern to policymakers. However, they are sufficiently distinct to outline 
separately as follows: 
 
1. Making up for the "lost decade" 
Investments in Israeli higher education and research essentially stagnated during the first decade 
of the 21st century. From 2000 until 2010 budgets effectively declined compared to the growth in 
population. By the middle of the decade, investments per student had declined by 9% compared 
to 19953 and the average age of faculty in exact sciences departments was over 55. Investment in 
research infrastructures also fell behind, forcing universities to rely heavily on donations.  
 
In output terms, the impacts of this stagnation were evident by the end of the decade, as 
evidenced by the decline in the country's share of world scientific publications which decreasing 
from 1.1% in 2000 to 0.9% in 2009,4 proportionately a radical decrease for a small country 
highly dependent on research and innovation. As far as citation impact is concerned, the decline 
was less acute, Israeli scientists' publications dropped from 12th to 13th place worldwide.5 . This 
lower drop in citation index rankings was attributed to the impact of papers of older researchers 
many of whom have reached retirement age. 
 
As a result of this stagnation, brain drain became an acute problem. While there are no up to 
date definitive comparative6 figures on brain drain, a study published in 20077 showed that 
Israelis with tertiary degrees had proportionately the highest rate of emigration to the US in the 
world. In the higher tiers of scientific research this has become such a major problem that it has 
become a defining policy priority. 
 
Stagnation is also evident in the government budget for industrial innovation as the OCS’s 
budget decreased by 30% (in real terms) from 2001 to 2011. The effects of this reduction were 
somewhat off-set by private investments but still many good industrial R&D projects suffered 
from lack of funds. 
                                                 
2 Innovation Union Competitiveness Report, 2011 edition, page 49 
3
 ERAWATCH Israel country report 2009 
4
 Innovation Union Competitiveness Report, 2011 edition, page 137 
5
 Research and Development Outputs in Israel, Samuel Neaman Institute, 2011 (in Hebrew) 
6Recent Israeli CBS publications provide some complementary national data in Hebrew: 
http://cbs.gov.il/reader/newhodaot/searh_text_hodaot.html?input_hod=%f9%e4%e5%fa+%ee%ee%e5%f9%eb
%fa 
7
 Israel's Brain Drain, Eric D. Gould and Omer Moav, Israel Economic Review Vol. 5 No. 1 (2007) 
 13 
 
 
 
2. Over Reliance on ICT 
The Israeli economy is heavily reliant on ICT based exports and clusters of industries based on a 
deep pool of talent that stretches from academe to small ICT based start-ups. The success of this 
industry is what enabled Israeli R&D based industries to attract substantial investment by 
business in ICT based industries, and this in turn was one of the reasons for the reduction of 
total government support of business based R&D by 36.3%8 compared to inflation adjusted 
prices for the year 2000. (In the past few years budgets for commercial R&D have increased fairly 
dramatically from a nadir in 2007 in reaction to the global economic crisis, but Israeli government 
investment in business R&D, once highest in the world, now lags behind countries like the US, 
the UK or Korea.) 
 
Policymakers have been aware of this over reliance for years, and have been encouraging Israeli 
industry to diversify through a variety of measures and initiatives. Yet they face a challenging 
dilemma: an in depth study9 has shown that government support of mainly ICT based industries 
is critical for economic growth in a highly competitive world, even though the majority of 
funding for innovation comes from the business sector. This means that a decision to divert a 
major part of the government resources intended to support industrial R&D to other new fields 
would cause extensive economic damage. Technology based exports, predominantly based on 
ICT, account for close to half of Israeli exports. There are no data on exactly what percentage of 
these exports are based on government support programmes, but by definition, government 
support is extended to the riskiest R&D ventures, those that give Israeli ICT exporters their 
competitive edge. Hence, diversion of resources from ICT would deprive Israeli industry of an 
important element of its competitive capacity. Yet not diversifying is also not a good long range 
option. The overall returns on the heavily ICT based Israeli venture capital industry have been 
disappointing during the past decade. Since a major part of the Israeli innovation system is 
predicated on creating new ICT companies this is a strong indicator showing that the innovation 
system needs new engines of growth.  
 
It is important to note that the distribution of government support, via OCS programs, across 
technological sectors have changed substantially in the last two decades. The main change is the 
rise of life sciences whose stakes are roughly 25% of all grants (compared to 10% a decade ago) 
on the expense of electronics which declined from 35% to 17% at that period. 
 
During the past decade, the government largely abandoned the field of thematic university based 
research in all civilian fields except for agriculture and most of the thematic research conducted 
in Israeli universities is through the country's participation in the EU Framework Programmes. 
Extensive thematic research is carried out is the country's large and classified defence R&D 
system, and there is anecdotal evidence10 of major spill-over effects to the civilian based ICT 
innovation system. This successful example shows that developing new areas of expertise 
requires not only extensive human and physical infrastructures, but also a judicious mix between 
thematic academic research and project-oriented R&D.  Hence, the challenge to develop non-
ICT based innovative industries must be cast not only in terms of the industrial policy, which is 
managed by the Office of the Chief Scientist in the Ministry of Industry Trade and Employment 
                                                 
8 Statement by Avi Hasson, Chief Scientist in the Ministry of Industry, Trade and Employment, October 2011 
9 The impact of government support to industrial R&D on the Israeli economy. (2008). Prof Shaul Lach, Dr. 
Shlomi Prizant, Daniel Wasserteil. Report Commissioned by the OCS 
10
 Eilam’s Arc, How Israel became a Military Technology Powerhouse, Sussex Academic Press, 2011 
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(OCS), but also in terms of research policy managed by Vatat (The Planning and Budgeting 
Committee of the council for Higher Education), and by the Israeli Science Foundation. 
 
3. Precarious VC Environment 
Venture Capital is an essential part of the Israeli innovation system. To put things in proportion, 
the total annual investment by VCs in Israeli technology start-ups during the past decade has 
usually been at least four times higher than the total government budget to support innovation in 
all firms from start-ups to major corporations. 
 
The latest 2012 Q4 data from IVC-Online, inform that in 2012, 575 Israeli high-tech companies 
raised €1.38 billion from local and foreign investors, a 10 percent decrease from €1.54 billion 
raised by 545 companies in 2011. VC-backed deals in which at least one venture capital fund 
participated, accounted for €985 million from a total of €1.38 billion raised in 2012. These 
venture-backed deals were down 22 percent from €1.27 billion in 2011. Israeli VC fund 
investments amounted to €371 million in 2012, 19 percent below the €559 million invested in 
2011. 
 
However, investments by Israeli VCs now account for only 25-30% of total VC investment in 
Israel, with the rest coming from foreign funds. This means that investments at the seed stage, 
which are typically handled by Israeli VCs and not their foreign counterparts, are in jeopardy. In 
addition, the funds from foreign VC funds are not committed a priori to investments in Israeli 
firms and could dry up at the next instance of the global financial crisis or be moved to more 
promising pastures in the Far East.  
 
The Israeli VC industry has been through several slumps since it was kick-started by the 
government in 1994 and has successfully bounced back. But the data for Israel correspond to a 
large degree with data from the US, because the industry as a whole has been delivering less than 
satisfactory returns (1.25% per year during the past decade compared to the 6.5% yield of the 
S&P index11.) The Israeli VC industry has become part of the system, and its diminishment could 
have a severe impact on company formation and the rest of the Israeli innovation system, thus 
presenting government with a major challenge
                                                 
11 Cambridge Index of US venture capital 
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4 ASSESSMENT OF THE NATIONAL 
INNOVATION STRATEGY 
 
 
4.1  National research and innovation priorities 
 
Research Priorities 
 
In 2012 four research areas have been designated by the Ministry of Science and Technology as 
national priority fields12: brain science, supercomputing and cyber security, oceanography and 
alternative transportation fuels. 
  
1. Brain science was chosen due to the rapid ageing of the population, which intensifies the 
need to find solutions for neuro-degenerative disorders (e.g. Parkinson's disease and 
Alzheimer's disease). 
  
2. A supercomputer is a computer at the frontline of current processing capacity, 
particularly speed of calculation. ICT is advancing at a rapid pace and due to the cyber 
threat, this area of research was chosen as a priority. This priority will be under the 
responsibility of the recently established Israel National Cyber Bureau, in cooperation 
with the Ministry of Science and Technology. Investment in this field will focus 
particularly on topics in artificial intelligence, advanced computing and cloud computing.  
 
3. Oceanography focus on extracting more extensive resources from the sea, e.g. fuel, food, 
drinking water and medicinal substances. The sea is thought to be an under-utilized 
resource with tremendous potential for research in such areas as maritime archaeology 
and artificial islands.  
 
4. The investment in alternative transportation fuels is based on a desire to find options 
that will enable Israel to end its dependence on Arab fuel sources, in the wake of a 
government decision in this regard. 
 
 
 
As mentioned above, up to the year 2012, there were no overarching research policy and no 
research priorities. Vatat viewed itself principally as a conduit for funds to universities and 
colleges. The introduction of a new six-year plan in 2010, gave higher education and research a 
30% increase in budget over and above the usual formulas for growth in the student body, and 
added an increase of about 9% in the number of academic researchers, and a near doubling of 
the allocation to the ISF for research grants. However, in addition to the increased budget, this 
six-year plan for the first time laid the ground for a research policy. 
 
The overall aim of the policy is to increase research excellence and increase targeted 
specialisation. The means to accomplish this is in the form of two initiatives. The first is a return 
to thematic funding through the I-CORE programme, under which up to 20 centres of 
excellence, funded partly directly by the government, are being set up as collaborations of Israeli 
                                                 
12 http://most.gov.il/English/research/Pages/default.aspx 
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researchers from universities, colleges, hospitals and research institutes. The I-CORE 
programme is based on the assumption that the Israeli research environment needs specific foci 
of excellence to compete in today's world. It has some departure from the previous approach, 
based on a tradition of very high university autonomy, under which policy makers made no 
thematic choices regarding areas to be funded. However, the topics for the I-COREs are selected 
via a wide consultation process with the entire academic community, and reflect its interests and 
priorities13. The second initiative is the change in the block funding formula, introduced in 2010, 
giving far higher priority to publications and rewarding institutions for having the best research 
performance in a specific field. The aim here was twofold, first to award funds for excellence and 
the second to encourage universities to specialise in specific areas in which they have a higher 
chance of excelling. The change here was less radical than the I-CORE programme, and was 
meant mainly to correct the errors of an old an inefficient block funding formula, but the impact 
of the new formula has already made several universities change their priorities. 
 
Innovation Priorities 
 
Unlike research, government support of innovation has operated for the past two decades under 
consistent policies with clearly defined priorities. While these priorities have changed over the 
years, the key principles and instruments used to stimulate innovation have remained remarkably 
stable. 
 
The key principle is that the role of the OCS is to reduce the risk of innovation in firms by 
shouldering part of the costs. In most cases, if the innovation project succeeds, companies repay 
royalties to the OCS. However, it is important to stress that the OCS does not regard itself as an 
investor, but rather as an agency that helps firms tread where they would not dare without some 
help. The three instruments currently in place are: the R&D Fund, which funds innovation 
projects in all firms; the incubator framework which supports start-ups; and the Magnet 
Organisation which deals with pre-competitive R&D through collaboration between the 
academic world and industry. 
 
There have been two main shifts in priorities during the past few years. The first, which was 
taken by the OCS working with the Finance Ministry in 2011, was a government decision to 
invest in a dedicated biotechnology venture capital fund.14 The creation of the fund was based on 
the realisation that years of consistent support by the OCS of biotechnology based innovation 
were not enough, and the government needed to reduce the financial risk of investing in biotech 
and not only the commercial risk of biotech innovation. A smaller initiative, also intended to 
increase diversification beyond ICT, supported the creation of a venture-based novel alternative 
energy R&D activity. 
 
The second major shift in priorities was the admission of many more priorities with mixed socio-
economic objectives into the policy mix. This shift, which started in 2005, with the introduction 
of a measure to stimulate innovation in traditional industries became more marked over the past 
few years as the funds devoted to the measure increased. Further measures were introduced 
prioritizing support for innovation in peripheral parts of Israel that traditionally have been 
poorer and enjoyed less of the benefits of high technology industry. It is important to note that 
special state prioritisation of socio-economic objectives, was essential because companies that 
                                                 
13 In this process, over 1200 Israeli researchers from various disciplines and institutions took part and suggested 
topics for I-COREs. 
14http://www.tamas.gov.il/NR/exeres/3C96E1CF-EDFA-4F16-BACE-216773805124.htm (Only in Hebrew) 
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enjoyed support under these measures would not have normally met the OCS criteria for 
funding, which are based mostly on international competitiveness. 
 
The last in-depth evaluation15 of the effectiveness of OCS policy was published in 2008, and 
concluded that the traditional policy of fostering innovation was highly effective. A new study 
which is due to publish its findings in 2013 will examine the effectiveness of OCS support to 
traditional industries. Until this study is published there are no means of judging whether the 
new, more societal priorities in the OCS policy mix do indeed act effectively to stimulate 
industrial investment in innovation. It is likely to take many more years to learn whether the 
biotechnology fund had indeed succeeded. 
 
Venture Capital Insurance 
 
In January 2012 the government launched a new programme intended to address the challenge 
faced by the venture capital industry by promising to insure 25% of the risk of Israeli 
institutional investors who invest in venture capital funds. The government plans to invest up to 
€40m in the programme, which is intended to stimulate investments of €160m by the Israeli 
institutional investors during the course of 2012, a critical year for Israeli VC funds. The fund 
sets guarantees on the IRR of up to 25% of the investment in the fund, so long as the fund 
invests in Israeli start-ups. This subsidy, or rather insurance, will be paid out as the fund winds 
down, at least seven years after its inception if the fund does not reach minimum targets on yield. 
 
Israeli venture capital funds have traditionally raised nearly all of their funds from institutional 
and other investors abroad, mainly the US. Poor returns on VC investments in the US during the 
past decade and the impact of the global financial crisis have reduced the proportion of venture 
capital in global institutional investors' capital allocations schemes. If Israeli institutional 
investors respond favourably, this will give Israeli funds an important kick-start in their fund 
raising activities abroad. 
 
 
 
4.2 Evolution and analysis of the policy mixes 
 
 
Until fairly recently, the only body in the research and innovation spheres of which it could be 
said that it had a policy mix was the OCS, where three main instruments were used in different 
ways to address a changing list of priorities. This has now changed. The introduction in year 
2010 of the new Vatat six-year plan combined with heightened involvement by the Finance 
Ministry in all spheres of research and innovation policy is producing a new reality in which 
measures introduced in one sphere can or should interact with other initiatives in different 
spheres.  
 
This new reality is best illustrated with a few examples. For many years Israel's vibrant ICT 
sector was the beneficiary of the very large defence R&D system. The sector enjoyed the benefits 
not only of technologies and a deep reservoir of thematic research, but most critically of human 
resources, young people intensively trained to develop and use cutting edge technologies under 
tight discipline. If one of the challenges outlined in section 3 points to the country's need to 
                                                 
15 The impact of government support to industrial R&D on the Israeli economy. (2008). Prof Shaul Lach, Dr. 
Shlomi Prizant, Daniel Wasserteil. Report Commissioned by the OCS 
 18 
 
diversify beyond ICT, then this need must be addressed by creating the necessary infrastructure, 
both in skills and the backbone of thematic research which Israeli industry is adept at using.  
 
The I-CORE programme can thus be seen in several dimensions. On the one hand it is intended 
to redress the damage of the "lost decade" in Israeli universities and act against brain drain, but it 
is also intended to create the research-based infrastructure of a new generation of competitive 
technologies that will act as a magnet to talented young researchers. This is a policy that goes 
beyond the immediate needs of the academic research system and touches on the entire 
innovation system. 
 
In a similar vein, the programme to insure part of the investment by Israeli institutional investors 
in Israeli VC funds was launched by the Finance Ministry as part of its comparative advantage 
programme, which is not necessarily related to the OCS. But if successful, this programme will 
release some of the funding pressure from the OCS programmes. Smaller programmes like 
Kamin bear the same hallmark. Intended to encourage academics to pursue research in areas of 
potential commercial interest, the programme will be managed by the OCS' Magnet 
Organisation, but was launched in coordination with the Council of Higher Education and the 
Finance Ministry. 
 
The apparent strength of this new coordination of policy mixes is that for the first time 
policymakers are looking at the entire range of issues that start with higher education through 
research to innovation policy. It is too early to look at actual weaknesses, but potential problems 
could arise from the fact that policy is being coordinated by a very small group of officials in the 
Finance Ministry and not by a body dedicated to the purpose. The main threat is that the new 
initiatives will not be sufficient to overcome the challenges outlined in section 2. The 
opportunity is based on the proven capacity of Israeli entrepreneurs to make use of the new 
technologies that hopefully will be developed as a result of the renewed vigour of the research 
sector. 
 
 
 
4.3 ASSESSMENT OF THE POLICY MIX 
 
Two of the three challenges outlined above, the quality of university research and the precarious 
status of Israeli venture capital, have been addressed by actions intended to directly mitigate the 
problems in the country's research and innovation systems. The third challenge, the need to 
diversify the ICT-centric technology sector, has been addressed by a variety of measures, but this 
is a long term and complex challenge that defies simple solutions. 
 
It is far too early to assess the effectiveness of the six-year Vatat plan and the I-CORE 
programme. The first indicators of success will be the number of new researchers retained by 
universities and the number of researchers who return to Israel to join I-CORE programmes. 
However, the real tests of the programme will be in general academic quality as measured both 
by bibliometric and other indicators, and by the commercial technologies that derive from this 
basic research. Both of these will take a long time to materialize. There has been some criticism 
in academic circles of the I-CORE programmes with academics saying that preferred status of I-
CORE centres will be at the expense of other academic researchers. But there is so far little 
evidence to support this claim. In general, the response to the challenge of the "lost decade" 
seems comprehensive and integrative, especially since it does not seek to turn the wheel back but 
to create a research environment suited to the conditions of the 21st century. 
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The assessment of the response to save the Israeli VC industry from its current state will be far 
quicker and results should be apparent towards the end of 2012. However, the effectiveness of 
the response depends on so many extraneous factors that it will be hard to judge on its own 
merits. Israeli institutional investors, like their colleagues in other countries, are judged by harsh 
criteria such as performance per quarter. The decision whether to lock up capital for seven to 10 
years because of the government's commitment to underwrite part of the risk depends to a large 
extent as much on current market conditions as on strategic considerations about the 
composition of each investor's portfolio. If Israeli investors do chose to enter the programme, 
this is only one part of each fund management company's struggle. They then have to persuade 
investors abroad, who should make up the majority of each limited partnership to invest in their 
fund despite the current tumultuous state of capital markets.  
 
The challenge of diversification beyond ICT is both more complex and more intriguing. Proof 
that it is achievable can be seen in the development during the past decade of a substantial 
cluster of Israeli companies in the field of medical devices, which is based on the skills and 
entrepreneurial drive of researchers and technologists from a broad range of fields ranging from 
medicine to ICT. However, even if the various measures promulgated and enacted by the OCS 
from biotechnology through nanotechnology to cleantech are successful, and if the I-CORE 
programme does indeed lead to the development of skills needed for the next generation of 
technologies, this might not be enough. The various clusters of Israeli companies in ICT are 
predicated on two additional conditions. The first is markets in a state of rapid growth in which 
relatively small Israeli companies can make their mark. The second is the existence of a financial 
ecosystem that can develop these companies. Even if these issues have not been resolved now, it 
is clear that various government initiatives, if seen in concert, are trying to address the 
complexities of this problem. 
 
Table 1: Policy measures and assessments 
Challenges 
Policy measures/actions
16
 Assessment in terms of appropriateness, efficiency and 
effectiveness 
Redressing 
the "lost 
decade" in 
academic 
research 
1. Six-year Vatat plan 
increasing research budgets 
and retaining more 
researchers 
2. I-CORE programmes for 
centres of research 
excellence 
The programme to repair and renew academic research 
appears to be both appropriate and comprehensive, but it is 
too early to appraise its effectiveness 
Over reliance 
on ICT-based 
innovation 
1. OCS programmes 
encouraging R&D in new 
fields including traditional 
industry. 
2. Government participation 
in dedicated biotech VC 
fund. 
OCS programmes are generally effective in addressing their 
immediate target. However the OCS cannot devote more of 
its limited budget devoted to non-ICT commercial R&D 
because the funds are needed by proven generators of jobs 
and wealth in ICT. The drive to diversify must go far beyond 
the immediate target of reducing the risk of commercial 
R&D. If the I-CORE programme does indeed produce both 
the knowledge and human skills needed to develop new 
fields, this is only part of the infrastructure needed for 
diversification. 
                                                 
16
 Changes in the legislation and other initiatives not necessarily related with funding are also included.  
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Challenges 
Policy measures/actions
16
 Assessment in terms of appropriateness, efficiency and 
effectiveness 
Precarious 
state of 
Venture 
Capital 
Government measure to 
insure 25% of the risk of 
Israeli institutional investors 
who join funds as limited 
partners 
The effectiveness of this measure is still too early to be 
judged, but success in re-funding the industry depends on 
many extraneous factors in world financial markets. 
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5 NATIONAL POLICY AND THE EUROPEAN 
PERSPECTIVE 
 
 
First and foremost, the brain drain of researchers particularly from the academic sector and the 
resulting short supply of such researchers have led to concrete measures to attract Israeli 
researchers working abroad back home. This is to be achieved by significantly increased budgets 
to HE and specifically to academic research, with improved research infrastructure as one of the 
targets. These policy changes are taking place within the new six-year plan for HE, whose 
implementation began in 2011. 
 
Israel already has a wide network of international cooperation R&D agreements, with countries 
both in Europe and elsewhere. Expansion of this network is definitely considered a target – with 
supervision of the network in large part by the Ministries of Industry, Trade and Employment 
and of Science and Technology. At the same time, expansion of the network is not being carried 
out as a national programme, though Israel's approval as a member of the OECD in 2010 is a 
definite step in the right direction 
 
Strengthening the universities in Israel is a national priority and the new six-year plan is the 
policy channel through which this target is to be achieved. It is recognized that strengthening 
academic research requires not only larger budgets – which the six-year plan will provide – but 
also more well-established ties between academia and the business sector. 
 
Technology transfer has been for some time a feature of all seven Israeli universities, but there 
are various government programmes in place, some fairly recent, which are designed to 
strengthen the ties between the two sectors. 
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Table 2: Assessment of the national policies/measures supporting the strategic ERA 
objectives (derived from ERA 2020 Vision) 
6  
ERA dimension 
Main challenges at national 
level 
Recent policy changes 
1 
Labour Market for 
Researchers 
1. To increase the number of 
researchers in Israel, 
particularly in HE. 
2. To attract Israeli researchers 
working abroad to return 
home. 
3. To recruit researchers from 
abroad to work in Israel. 
4. To provide incentives to 
increase the number of 
science and technology 
university students and to 
stem the decline in 
technology track secondary 
schools. 
Increased budget to universities in order to 
open more positions for researchers; 
Renewed budgeting model which rewards 
universities for an improved faculty/student 
ratio; 
Continuing establishment of up to 20 
Excellence Centres, as part of the new six-
year plan – whose implementation began in 
2011 - to support university R&D. The first 
four centres have already begun functioning 
in 2011. During 2013, eleven new centres will 
be established. The Centres aim at meeting all 
three main challenges: to increase the number 
of researchers, to attract Israeli researchers 
back home and to offer suitable research 
facilities to attract foreign researchers to work 
in Israel. 
2 
Cross-border 
cooperation 
1. To expand the current list 
of bilateral R&D 
agreements between Israel 
and various EU and other 
countries. 
2. To encourage R&D 
entities to apply to 
Framework Programme 7 
There are no national programmes for cross-
border cooperation and no recent policy 
changes connected with such cooperation. 
Rather there is an ongoing target of 
enhancing existing connections between 
Israel and countries in the EU and elsewhere, 
via bilateral R&D agreements on the clear 
understanding that such connections are 
crucial for bolstering Israel's innovation 
sector. A recent bilateral agreement, signed in 
2011, is the Shanghai-Israel Programme for 
Industrial R&D which aims at the 
development of products or processes leading 
to commercialisation in global markets. 
3 
World class research 
infrastructures 
1. To radically improve the 
overall research 
infrastructure of Israel's 
HE sector. 
 
Once the connection was made between the 
sorely lacking research infrastructure of 
Israel's universities and the growing brain 
drain of researchers, it was understood, 
within the new six-year plan for the HE 
sector, that the aim of attracting back to Israel 
researchers working abroad had as a 
necessary criterion for success a dramatic 
improvement in infrastructure. The 
implementation of the new plan began in 
2011 and includes significant budgets for 
infrastructure improvement. Work is 
currently being done on the creation of an 
Israeli RI roadmap, not as part of the official 
ESFRI, but as a necessary tool for tracking 
the development of R&D infrastructure in 
Israel. 
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6  
ERA dimension 
Main challenges at national 
level 
Recent policy changes 
4 Research institutions 
1. To increase the share of 
HERD in GERD. 
The share of HERD in 2010 was 12.8%, 
down from 32% in 1990. The new six-year 
plan has set an increased share of HERD as 
one of its aims. It is true that the share of 
BERD has increased to compensate for the 
declining share of HERD over the past 20 
years, but the effect of global crises on BERD 
in recent years has clarified the need to 
strengthen HERD, by providing both more 
finance and more human resources. 
5 
Public-private 
partnerships 
1. To widen the connection 
between university R&D 
and industry. 
The understanding here is clear: expanding 
academic R&D has to be accompanied by 
providing channels of connection with 
industry in order to guarantee 
commercialisation of research. More 
emphasis on non-ICT research and more 
thematic research (see Chapter 2 of this 
report) is being paralleled by strengthening of 
the ties between the academic sector and 
industry, with government programmes such 
as Magnet and Kamin aimed at achieving 
stronger ties.  
6 
Knowledge circulation 
across Europe 
Not applicable to Israel  
7 
International 
Cooperation 
No specific challenges Israel has a far-reaching network of 
international cooperation with many 
countries both in Europe and elsewhere, and 
works continually to expand the network.  
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8 LIST OF ABBREVIATIONS 
 
BERD Business Expenditures for Research and Development 
CERN European Organisation for Nuclear Research 
ERA European Research Area 
CHE Council of Higher Education 
COST European Cooperation in Science and Technology 
EPO European Patent Office 
ERA European Research Area  
ERA-NET European Research Area Network 
ESA European Recovery Programme Fund 
ERC European Research Council 
ESFRI European Space Agency 
FP 
European Framework Programme for Research and Technology 
Development 
EU-27 European Union including 27 Member States 
FDI Foreign Direct Investments 
FP7 7th Framework Programme 
GBAORD Government budget appropriations on R&D 
GDP Gross Domestic Product 
GERD Gross Expenditure on R&D 
GOVERD Government Intramural Expenditure on R&D  
GUF General University Funds 
HEI Higher education institutions 
HERD Higher Education Expenditure on R&D 
HES Higher education sector 
IP Intellectual Property 
ISF Israel Science Foundation 
M&A Mergers and Acquisitions 
OECD Organisation for Economic Co-operation and Development 
MOITAL Ministry of Industry, Trade and Labour 
OCS Public  Research Organization 
PRO Office of the Chief Scientist, Ministry of Industry, Trade and Employment 
R&D Research and development 
RI Research Infrastructures 
RDI Research Development and Innovation 
RTDI Research Technological Development and Innovation 
S&P Standard and Poor 
SF Structural Funds 
SME Small and Medium Sized Enterprise 
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S&T Science and technology 
Vatat 
The Hebrew Acronym for the Planning and Budgeting Committee of the 
Council of Higher Education 
VC Venture Capital 
 
BERD Business Expenditures for Research and Development 
CERN European Organisation for Nuclear Research 
ERA European Research Area 
CHE Council of Higher Education 
COST European Cooperation in Science and Technology 
EPO European Patent Office 
ERA European Research Area  
ERA-NET European Research Area Network 
ESA European Recovery Programme Fund 
ERC European Research Council 
ESFRI European Space Agency 
FP 
European Framework Programme for Research and Technology 
Development 
EU-27 European Union including 27 Member States 
FDI Foreign Direct Investments 
FP7 7th Framework Programme 
GBAORD Government budget appropriations on R&D 
GDP Gross Domestic Product 
GERD Gross Expenditure on R&D 
GOVERD Government Intramural Expenditure on R&D  
GUF General University Funds 
HEI Higher education institutions 
HERD Higher Education Expenditure on R&D 
HES Higher education sector 
IP Intellectual Property 
ISF Israel Science Foundation 
M&A Mergers and Acquisitions 
OECD Organisation for Economic Co-operation and Development 
MOITAL Ministry of Industry, Trade and Labour 
PRO Public  Research Organization 
OCS Office of the Chief Scientist, Ministry of Industry, Trade and Employment 
R&D Research and development 
RI Research Infrastructures 
RDI Research Development and Innovation 
RTDI Research Technological Development and Innovation 
S&P Standard and Poor 
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SF Structural Funds 
SME Small and Medium Sized Enterprise 
S&T Science and technology 
Vatat 
The Hebrew Acronym for the Planning and Budgeting Committee of the 
Council of Higher Education 
VC Venture Capital 
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Abstract 
This analytical country report is one of a series of annual ERAWATCH reports produced for EU Member States and Countries Associated to the 
Seventh Framework Programme for Research of the European Union (FP7). The main objective of the ERAWATCH Annual Country Reports is to 
characterise and assess the performance of national research systems and related policies in a structured manner that is comparable across 
countries. 
The Country Report 2012 builds on and updates the 2011 edition. The report identifies the structural challenges of the national research and 
innovation system and assesses the match between the national priorities and the structural challenges, highlighting the latest developments, their 
dynamics and impact in the overall national context. They further analyse and assess the ability of the policy mix in place to consistently and 
efficiently tackle these challenges. These reports were originally produced in December 2012, focusing on policy developments over the previous 
twelve months. 
The reports were produced by independent experts under direct contract with IPTS. The analytical framework and the structure of the reports have 
been developed by the Institute for Prospective Technological Studies of the Joint Research Centre (JRC-IPTS) and Directorate General for Research 
and Innovation with contributions from external experts. 
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As the Commission’s in-house science service, the Joint Research Centre’s mission is to provide EU policies with 
independent, evidence-based scientific and technical support throughout the whole policy cycle. 
 
Working in close cooperation with policy Directorates-General, the JRC addresses key societal challenges while 
stimulating innovation through developing new standards, methods and tools, and sharing and transferring its know-
how to the Member States and international community. 
 
Key policy areas include: environment and climate change; energy and transport; agriculture and food security; health 
and consumer protection; information society and digital agenda; safety and security including nuclear; all supported 
through a cross-cutting and multi-disciplinary approach. 
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